A common virus may help inform treatment planning for stem cell transplant patients

December 7, 2017, Virginia Commonwealth University

Most healthy people barely notice infection with the human cytomegalovirus (hCMV), a form of the herpes virus that has evolved with humans over thousands of years and usually lays dormant in the body after initial infection. Now, in a study recently published in the journal PLOS ONE, a team of scientists from VCU Massey Cancer Center have shown a genetic relationship between the reactivation of hCMV and the onset of graft-versus-host disease (GVHD), a potentially deadly condition in which the immune system attacks healthy tissue following a bone marrow or stem cell transplant.

This new finding is the latest in a line of research led by physician-scientist, Amir Toor, M.D. Toor and his colleagues have been working to create computer models that simulate immune system recovery following stem cell transplantation in hopes of reducing complications such as GVHD and making transplantation an option for more patients. While the relationship between GVHD and hCMV has been described in medical literature since the 1980s, the connection was not well understood until one of Toor's mentees, Charles Hall, M.S., showed genetic similarities between the virus and tissue expressing GVHD.

"Until now, physicians have taken a 'wait and see' approach to antiviral therapies following transplantation," says Toor, a hematologist-oncologist in the Bone Marrow Transplant Program and member of the Developmental Therapeutics research program at VCU Massey Cancer Center as well as professor in the Division of Hematology, Oncology and Palliative Care at the VCU School of Medicine. "But, based on our data, we believe there is a case for early intervention with personalized antiviral treatments following stem cell transplantation in order to suppress hCMV reactivation."

Toor and his team sequenced the DNA of 77 stem cell donors and their recipients. They found a significant number of patients (18) experienced hCMV reactivation and GVHD, and a majority (13) of those patients experienced hCMV reactivation prior to GVHD onset. Using the information they uncovered through DNA sequencing along with data from a new database established by the Center for the Study of Biological Complexity at VCU called Cross Reactive Open Source Sequence Database, developed by Charles Hall, M.S., and Vishal Koparde, Ph.D., the team uncovered a novel connection between the virus and GVHD.

The scientists found similarities in HLA-bound peptide sequences between human and hCMV genomes. The HLA (human leukocyte antigen) is a system of genes responsible for regulating immune responses, and peptides are short chains of amino acids that play key roles in regulating the activities of other molecules. It turns out that hCMV peptides are very similar to peptides expressed in GVHD-affected tissue.

"We developed a computer model that shows how the immune system can react to hCMV peptides to trigger a graft-versus-host response," explained Toor. "By sequencing the DNA of stem cell donors and recipients, we believe we can use computer modeling to further identify patients at risk and better personalize post-transplant care to decrease the potential for graft-versus-host disease."

Toor hopes to further explore the relationship between hCMV and GVHD. His team is currently working to secure funding to apply their model to larger patient data sets.

Explore further: Researchers identify patients at risk for stem cell transplant complications

More information: Charles E. Hall et al. Sequence homology between HLA-bound cytomegalovirus and human peptides: A potential trigger for alloreactivity, PLOS ONE (2017). DOI: 10.1371/journal.pone.0178763

Related Stories

Researchers identify patients at risk for stem cell transplant complications

June 8, 2015
Researchers at VCU Massey Cancer Center's Bone Marrow Transplant Program have recently published findings from a phase 2 clinical trial that demonstrate lymphocyte recovery in related and unrelated stem cell transplant recipients ...

Antibodies from rabbits improve survival and relapse outcomes of leukemia and myelodysplasia

July 6, 2012
Researchers at Virginia Commonwealth University (VCU) Massey Cancer Center's Bone Marrow Transplant Program have demonstrated that the use of antibodies derived from rabbits can improve the survival and relapse outcomes of ...

Depletion of naive T cells from stem cell grafts limits chronic graft-versus host disease

June 8, 2015
Stem cell transplantation is used to treat hematologic malignancies, such as leukemia. Patients that receive donor cells are at risk of developing graft-versus host disease (GVHD). This potentially fatal complication results ...

Purging a virus from organ transplants

April 7, 2015
Human cytomegalovirus (HCMV) is an extremely common virus, which as other members of the herpes virus family causes life-long infections in humans. Most individuals are exposed to HCMV during childhood, yet symptoms can be ...

Scientists ID human protein essential for human cytomegalovirus replication

May 11, 2017
Scientists have demonstrated that a human protein known as valosin containing protein (VCP) is essential for replication of human cytomegalovirus (HCMV). The findings, published in PLOS Pathogens, identify VCP as a potential ...

New test helps guide treatment for bone marrow transplant patients with graft vs. host disease

January 13, 2015
A new test can guide treatment for patients with graft versus host disease (GVHD), an often life-threatening complication of bone marrow and stem cell transplants, according to research from the University of Michigan published ...

Recommended for you

Breakthrough article on mechanistic features of microRNA targeting and activity

March 23, 2018
Giovanna Brancati and Helge Grosshans from the FMI have described target specialization of miRNAs of the let-7 family. They identified target site features that determine specificity, and revealed that specificity can be ...

Boosting enzyme may help improve blood flow, fitness in elderly

March 22, 2018
As people age, their blood-vessel density and blood flow decrease, which is why it's harder to maintain muscle mass after 40 and endurance in the later decades, even with exercise. This vascular decline is also one of the ...

Scientists pinpoint cause of vascular aging in mice

March 22, 2018
We are as old as our arteries, the adage goes, so could reversing the aging of blood vessels hold the key to restoring youthful vitality?

Sulfur amino acid restriction diet triggers new blood vessel formation in mice

March 22, 2018
Putting mice on a diet containing low amounts of the essential amino acid methionine triggered the formation of new blood vessels in skeletal muscle, according to a new study from Harvard T.H. Chan School of Public Health. ...

Cold can activate body's 'good' fat at a cellular level, study finds

March 21, 2018
Lower temperatures can activate the body's 'good' fat formation at a cellular level, a new study led by academics at The University of Nottingham has found.

Gradual release of immunotherapy at site of tumor surgery prevents tumors from returning

March 21, 2018
A new study by Dana-Farber Cancer Institute scientists suggests it may be possible to prevent tumors from recurring and to eradicate metastatic growths by implanting a gel containing immunotherapy during surgical removal ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.